Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2010

01-02-2010 | Editorial

Identity of mysterious CD4+CD25-Foxp3+cells in systemic lupus erythematosus

Author: David A Horwitz

Published in: Arthritis Research & Therapy | Issue 1/2010

Login to get access

Abstract

Various abnormalities in CD4+CD25+ regulatory T cells (Tregs) in systemic lupus erythematosus (SLE) include increased Foxp3+ cells that are CD25 negative. Barring methodological technical factors, these cells could be atypical Tregs or activated non-Treg CD4+ cells that express Foxp3. Two groups have reached opposite conclusions that could possibly reflect the subjects studied. One group studied untreated new-onset SLE and suggested that these T cells were mostly CD25-Foxp3+ non-Tregs. The other group studied patients with long-standing disease and suggested that these cells are mostly dysfunctional Tregs. A third group reported increased Foxp3+CD4+CD25dim rather than CD25- cells in active SLE and these were also non-Tregs. Thus, it is likely that not all Foxp3+ T cells in SLE have protective suppressive activity.
Literature
1.
go back to reference Yang HX, Zhang W, Zhao LD, Li Y, Zhang FC, Tang FL, He W, Zhang X: Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?. Arthritis Res Ther. 2009, 11: R153-10.1186/ar2829.PubMedCentralCrossRefPubMed Yang HX, Zhang W, Zhao LD, Li Y, Zhang FC, Tang FL, He W, Zhang X: Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?. Arthritis Res Ther. 2009, 11: R153-10.1186/ar2829.PubMedCentralCrossRefPubMed
2.
go back to reference Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C: Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus. J Immunol. 2009, 182: 1689-1695.CrossRefPubMed Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C: Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus. J Immunol. 2009, 182: 1689-1695.CrossRefPubMed
4.
go back to reference Zhang B, Zhang X, Tang F, Zhu L, Liu Y, Chen W, Lipsky P: Clinical significance of increased CD4+CD25-Foxp3+T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis. 2008, 67: 1037-1040. 10.1136/ard.2007.083543.CrossRefPubMed Zhang B, Zhang X, Tang F, Zhu L, Liu Y, Chen W, Lipsky P: Clinical significance of increased CD4+CD25-Foxp3+T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis. 2008, 67: 1037-1040. 10.1136/ard.2007.083543.CrossRefPubMed
5.
go back to reference Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006, 203: 1701-1711. 10.1084/jem.20060772.PubMedCentralCrossRefPubMed Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006, 203: 1701-1711. 10.1084/jem.20060772.PubMedCentralCrossRefPubMed
6.
go back to reference Nadkarni S, Mauri C, Ehrenstein MR: Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med. 2007, 204: 33-39. 10.1084/jem.20061531.PubMedCentralCrossRefPubMed Nadkarni S, Mauri C, Ehrenstein MR: Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med. 2007, 204: 33-39. 10.1084/jem.20061531.PubMedCentralCrossRefPubMed
7.
go back to reference Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S: Functional delineation and diff erentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 2009, 30: 899-911. 10.1016/j.immuni.2009.03.019.CrossRefPubMed Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S: Functional delineation and diff erentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 2009, 30: 899-911. 10.1016/j.immuni.2009.03.019.CrossRefPubMed
8.
go back to reference Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, Stray-Pedersen A, Ocheltree EL, Greenberg PD, Ochs HD, Rudensky AY: Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA. 2006, 103: 6659-6664. 10.1073/pnas.0509484103.PubMedCentralCrossRefPubMed Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, Stray-Pedersen A, Ocheltree EL, Greenberg PD, Ochs HD, Rudensky AY: Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA. 2006, 103: 6659-6664. 10.1073/pnas.0509484103.PubMedCentralCrossRefPubMed
9.
go back to reference Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, Strober W: TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol. 2004, 172: 834-842.CrossRefPubMed Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, Strober W: TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol. 2004, 172: 834-842.CrossRefPubMed
10.
go back to reference Belkaid Y, Tarbell K: Regulatory T cells in the control of host-microorganism interactions (*). Annu Rev Immunol. 2009, 27: 551-589. 10.1146/annurev.immunol.021908.132723.CrossRefPubMed Belkaid Y, Tarbell K: Regulatory T cells in the control of host-microorganism interactions (*). Annu Rev Immunol. 2009, 27: 551-589. 10.1146/annurev.immunol.021908.132723.CrossRefPubMed
11.
go back to reference Hippen KL, Harker-Murray P, Porter SB, Merkel SC, Londer A, Taylor DK, Bina M, Panoskaltsis-Mortari A, Rubinstein P, Van Rooijen N, Golovina TN, Suhoski MM, Miller JS, Wagner JE, June CH, Riley JL, Blazar BR: Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigenpresenting cells. Blood. 2008, 112: 2847-2857. 10.1182/blood-2008-01-132951.PubMedCentralCrossRefPubMed Hippen KL, Harker-Murray P, Porter SB, Merkel SC, Londer A, Taylor DK, Bina M, Panoskaltsis-Mortari A, Rubinstein P, Van Rooijen N, Golovina TN, Suhoski MM, Miller JS, Wagner JE, June CH, Riley JL, Blazar BR: Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigenpresenting cells. Blood. 2008, 112: 2847-2857. 10.1182/blood-2008-01-132951.PubMedCentralCrossRefPubMed
Metadata
Title
Identity of mysterious CD4+CD25-Foxp3+cells in systemic lupus erythematosus
Author
David A Horwitz
Publication date
01-02-2010
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2010
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2894

Other articles of this Issue 1/2010

Arthritis Research & Therapy 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.